Ventyx Biosciences, Inc. (VTYX)
NASDAQ: VTYX · Real-Time Price · USD
8.72
+0.72 (9.00%)
At close: Dec 5, 2025, 4:00 PM EST
8.71
-0.01 (-0.11%)
After-hours: Dec 5, 2025, 7:57 PM EST
Ventyx Biosciences Market Cap
Ventyx Biosciences has a market cap or net worth of $622.25 million as of December 5, 2025. Its market cap has increased by 394.38% in one year.
Market Cap
622.25M
Enterprise Value
439.63M
1-Year Change
394.38%
Ranking
Category
Stock Price
$8.72
Market Cap Chart
Since the IPO on October 21, 2021, Ventyx Biosciences's market cap has decreased from $782.89M to $622.25M, a decrease of -20.52%. That is a compound annual growth rate of -5.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 622.25M | 301.82% |
| Dec 31, 2024 | 154.86M | 6.21% |
| Dec 29, 2023 | 145.80M | -92.15% |
| Dec 30, 2022 | 1.86B | 85.92% |
| Dec 31, 2021 | 998.89M | 27.59% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 908.36B |
| Johnson & Johnson | 487.83B |
| AbbVie | 404.22B |
| UnitedHealth Group | 302.09B |
| AstraZeneca | 279.81B |
| Novartis AG | 255.73B |
| Merck & Co. | 250.41B |
| Abbott Laboratories | 218.05B |